Experts Warn 7-OH Is an Emerging Opioid Threat as Fatal Overdoses and Hospitalizations Rise

Why it matters

Concentrated 7-OH products — sold openly at smoke shops and gas stations in tablet, gummy, and drink form — are triggering fatal overdoses, respiratory emergencies, and hospitalizations at rates that experts say rival traditional opioids, yet most consumers don't know what they're buying.

The big picture

7-hydroxymitragynine occurs naturally in kratom leaves at trace levels (typically below 2% of total alkaloids), but a new wave of synthetically concentrated 7-OH products has flooded the unregulated supplement market. The FDA moved to recommend Schedule I scheduling for 7-OH in July 2025, and the DEA and HHS are collaborating on a regulatory framework. Meanwhile, states including Texas have filed lawsuits against manufacturers selling products with up to 96% 7-OH concentrations. Experts draw a sharp distinction between these products and traditional whole-leaf kratom, cautioning that broad bans targeting all kratom could have unintended consequences for people managing chronic pain or opioid withdrawal.

Key findings

• Three fatal overdoses linked to concentrated 7-OH products have been confirmed in Los Angeles County; more than 10 patients in Pennsylvania required mechanical ventilation following 7-OH exposure.
• Texas Poison Center Network received 192 reports involving kratom or 7-OH in the first 9 months of 2025, up from 107 for all of 2024.
• Texas Attorney General Ken Paxton has sued two California-based retailers for selling 7-OH products with concentrations up to 96%.
• Naturally occurring 7-OH typically represents less than 2% of kratom's total alkaloid content; concentrated synthetic products are pharmacologically distinct.
• HHS confirmed it is working with the DEA to establish a regulatory framework targeting synthetic and highly concentrated 7-OH products.
• A 2-year-old child reportedly required emergency resuscitation after consuming a candy-based 7-OH formulation.

What they say

"Concentrated 7-OH products represent an emerging public health concern," said C. Austin Zamarripa, professor of psychiatry and behavioral sciences at Johns Hopkins University. "Many people use traditional kratom products for pain, withdrawal, or as an alternative to more dangerous substances, and collapsing all kratom products into one category could lead to overly broad policy responses."

Bottom line

Highly concentrated synthetic 7-OH products are causing real harm — fatal overdoses, pediatric emergencies, mass hospitalizations — and experts say the evidence demands urgent targeted regulation, not a blanket ban on all kratom.